Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease
Abroad (travel likely)RecruitingPHASE2
Conditions
Pulmonary Fibrosis, Interstitial Lung Disease · Idiopathic Pulmonary Fibrosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Aarhus University Hospital, Aarhus N, Denmark
Kardiologisk Forskningsenhed 2161, Rigshospitalet, Copenhagen, Denmark
Contact: Study coordinator (Rikke Brandt Forskningssygeplejerske) · rikke.brandt@regionh.dk · +45 35 45 84 30Tartu University Hospital,, Tartu, Estonia
Division of Respiratory Sciences, Glenfield Hospital, Leicester, United Kingdom
University of East Anglia, Norwich, United Kingdom
Study leads
Ole Hilberg, Proffesor
Study Director
Sygehus Lillebælt - Vejle